Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
Condition(s):Liver MalignancyLast Updated:October 16, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Liver MalignancyLast Updated:October 16, 2023Recruiting
Condition(s):Lung CancerLast Updated:December 7, 2023Recruiting
Condition(s):Prostate CancerLast Updated:March 15, 2024Recruiting
Condition(s):Lung NeoplasmLast Updated:November 2, 2023Recruiting
Condition(s):Recurrent Head and Neck CarcinomaLast Updated:April 12, 2023Recruiting
Condition(s):Pancreatic CancerLast Updated:March 15, 2024Not yet recruiting
Condition(s):Prostate Cancer; Cancer of the ProstateLast Updated:March 21, 2024Recruiting
Condition(s):Liver Metastases; Colorectal Cancer; Anal Canal Cancer; Gastrointestinal Neuroendocrine TumorsLast Updated:December 8, 2023Recruiting
Condition(s):Metastatic Malignant Solid Neoplasm; LymphomaLast Updated:October 10, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:October 27, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.